Gabapentin for Perimenopause Hot Flashes: What You Should Know Before You Start
Gabapentin is prescribed off-label for hot flashes and sleep in perimenopause. Learn how it works, the evidence, side effects, and how it compares to other options.
An Unexpected Option for Hot Flashes
Gabapentin was originally developed to treat epilepsy and is also FDA-approved for nerve pain from shingles. So it might seem surprising that it shows up in conversations about perimenopause. But gabapentin has been prescribed off-label for hot flashes for decades, and there is enough clinical trial evidence to make it a recognized, if not first-line, non-hormonal option for vasomotor symptoms.
When estrogen is not an option, or when a woman has tried it and not tolerated it, providers look for alternatives. SSRIs, SNRIs, clonidine, and more recently fezolinetant are in that conversation. Gabapentin sits in that landscape as an option with a particular profile: it tends to help most with nighttime hot flashes and may improve sleep at the same time. For women whose biggest complaint is being woken up repeatedly by night sweats, that dual benefit is worth understanding.
This article explains how gabapentin works for hot flashes, what the clinical evidence shows, what side effects to expect, and who is most likely to benefit from it. If you and your provider are weighing your options, this is the background information that will help that conversation be more productive.
How Gabapentin Works for Hot Flashes
Gabapentin works by binding to calcium channels in nerve cells and reducing abnormal neuronal firing. Its mechanism for relieving hot flashes is not fully understood, but researchers believe it modulates activity in the hypothalamus, the part of the brain that regulates body temperature. By dampening the overactive neural signaling that triggers vasomotor events, it may help stabilize the thermoregulatory response that is out of balance during perimenopause.
This is a different mechanism from SSRIs and SNRIs, which work on serotonin and norepinephrine pathways. It is also different from fezolinetant, which specifically blocks the neurokinin B receptor. Gabapentin's broader effect on neuronal firing is less targeted, which is part of why it has a different side effect profile and why it also affects sleep, not just hot flashes.
The sedating effect of gabapentin is actually one of its useful features for women with hot flash-driven sleep disruption. For women who are woken multiple times per night by night sweats and then cannot fall back asleep, a low-dose gabapentin taken at bedtime can address both the frequency of nighttime vasomotor events and the difficulty returning to sleep after they happen.
What the Clinical Evidence Shows
Several randomized controlled trials have studied gabapentin for hot flashes, with results that are moderately encouraging. A landmark trial published in JAMA in 2006 compared gabapentin at 900 mg per day (300 mg three times daily) to placebo in 197 women and found a 45 percent reduction in hot flash composite score versus a 29 percent reduction in the placebo group. The difference was statistically significant.
Other trials have used different doses and dosing schedules. Evening-only dosing, typically 300 to 900 mg taken a few hours before bed, has been studied specifically for nighttime symptoms and shows benefit for sleep quality alongside reduced night sweats. A 2010 trial in the journal Menopause found that gabapentin at 300 mg three times daily reduced hot flash frequency by about 66 percent, which is on the higher end of what non-hormonal options typically achieve.
The American College of Obstetricians and Gynecologists (ACOG) and the Menopause Society recognize gabapentin as a reasonable non-hormonal option for vasomotor symptoms. It is not a first-choice recommendation in most guidelines, but it is explicitly included as an option for women who cannot use estrogen or who have not had adequate relief from SSRIs or SNRIs.
Dosing and How It Is Typically Prescribed
For hot flashes, gabapentin is typically started at a low dose and increased gradually depending on response and tolerability. A common starting point is 300 mg at night, which targets nighttime symptoms while minimizing daytime sedation. If nighttime-only dosing does not provide enough relief for daytime hot flashes, the dose can be split across morning and evening, or providers may increase to 300 mg three times daily.
The therapeutic range studied in hot flash trials has generally been 900 mg to 1800 mg per day, though many women find benefit at the lower end. Going higher does not always produce proportionally greater benefit and increases side effect burden. Your provider will guide the titration based on how you respond.
Gabapentin is available in both immediate-release and extended-release formulations. Extended-release gabapentin (Horizant) was specifically FDA-approved for restless leg syndrome and may be prescribed for sleep-related concerns, though it is also off-label for hot flashes. Compounded gabapentin is sometimes used as well. Because gabapentin is a generic medication, it is generally affordable, which is one practical advantage compared to newer non-hormonal options.
Side Effects: What You Need to Know Going In
The most common side effects of gabapentin are sedation, dizziness, and fatigue. These are most pronounced when starting or increasing the dose and often improve over one to two weeks as your body adjusts. Taking gabapentin at night can minimize daytime sedation, which is another reason evening dosing is often preferred for perimenopause applications.
Weight gain is a potential side effect that is worth knowing about before starting. Not all women experience it, but clinical trials of gabapentin for various conditions have documented modest weight gain in some users, particularly at higher doses or with long-term use. If weight management is already a concern during perimenopause, this is a conversation to have explicitly with your provider.
Gabapentin also carries a label warning about dependence and withdrawal, which is important context. It is not classified as a controlled substance in most U.S. states (though some have moved to regulate it more strictly), but stopping gabapentin abruptly after regular use can cause withdrawal symptoms including anxiety, insomnia, and in some cases seizures at very high doses. This means tapering rather than stopping suddenly, which is important to understand before you start. It is not a casual supplement situation, it is a medication with real pharmacological effects.
Who Is a Good Candidate for Gabapentin for Hot Flashes
Gabapentin tends to be a particularly good fit for women whose hot flashes are most disruptive at night, who have concurrent sleep difficulties, and who have found SSRIs or SNRIs either ineffective or intolerable due to side effects like sexual dysfunction or nausea. Women with nerve pain conditions who might already benefit from gabapentin for another reason are also sometimes considered.
Gabapentin is generally not the best option if you have a job or lifestyle where daytime sedation would be dangerous or significantly impairing. Driving and operating machinery can be affected, especially early in treatment. Women who are already struggling with significant fatigue during perimenopause should also discuss whether the added sedation will worsen their quality of life more than the hot flash relief helps it.
Women with kidney disease require dose adjustment because gabapentin is cleared through the kidneys. It should be used with caution alongside other central nervous system depressants including alcohol, benzodiazepines, and opioids because the sedating effects combine. Your prescriber will need your full medication and health history before recommending gabapentin.
Gabapentin vs. Other Non-Hormonal Options
When comparing gabapentin to other non-hormonal options for hot flashes, the main comparators are SSRIs (like paroxetine CR, which is FDA-approved for hot flashes as Brisdelle), SNRIs (like venlafaxine), and now fezolinetant (Veozah). Clonidine is another option, discussed separately.
SSRIs and SNRIs tend to have better evidence specifically for daytime hot flashes and have a more well-characterized long-term safety record. They can cause sexual dysfunction and nausea, which are real concerns for some women. Gabapentin's advantage is primarily the nighttime/sleep benefit and the absence of sexual side effects. Fezolinetant offers stronger hot flash reduction overall (around 60 percent frequency reduction) and is more targeted, but it is significantly more expensive and requires liver function monitoring.
In practice, the best non-hormonal option depends on your specific symptom pattern, your other health conditions, your medication history, and your provider's experience. Some women try gabapentin specifically because they want to avoid antidepressants for non-psychiatric symptoms. Others end up on gabapentin after finding that SSRIs made their sleep worse or caused other intolerable effects. The non-hormonal landscape is not one-size-fits-all.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Gabapentin is a prescription medication used off-label for perimenopause symptoms. It has real side effects, dependence potential, and contraindications that require evaluation by a licensed healthcare provider. Do not start, stop, or change this medication without medical supervision. Stopping gabapentin abruptly can cause withdrawal symptoms.
Information in this article reflects clinical research and prescribing guidance available as of early 2026.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.